PB 93 of 2018

National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2018 (No. 9)

National Health Act 1953

___________________________________________________________________________

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated   25th October 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1               Name of Instrument

(1)           This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2018 (No. 9).

(2)           This Instrument may also be cited as PB 93 of 2018.

2               Commencement

This Instrument commences on 1 November 2018.

3               Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1  Amendments

[1]           Schedule 1, after entry for Estradiol with norethisterone in the form Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8

insert:

[2]           Schedule 1, after entry for Etanercept in the form Injection 50 mg in 1 mL single use auto injector, 4 [Maximum quantity or number of units: 1; Maximum number of repeats: 5]

insert:

[3]           Schedule 1, after entry for Etanercept in the form Injection set containing 4 vials powder for injection 25 mg and 4 pre filled syringes solvent 1 mL [Maximum quantity or number of units: 2; Maximum number of repeats: 5]

insert:

[4]           Schedule 1, after entry for Etonogestrel in the form Subcutaneous implant 68 mg

insert: